SpaceX starts trading on Nasdaq on June 12, and the IPO pipeline is already messy. The company is set to price 555.6 million shares at $135 each for about $75 billion, according to the report from Finance Magnates. Bloomberg, via the same piece, described the deal as oversubscribed at a valuation near $1.8 trillion.
What’s unusual is not the headline size. It’s who can buy in before the first tick. SpaceX reserved up to 30% of the offering for retail through US brokers, which the story notes is roughly triple the typical retail allocation. That bigger retail bucket triggered a scramble across Wall Street brokers and offshore crypto platforms.
Retail slice versus “pre-IPO” marketing
The Finance Magnates report frames the fight as access versus exposure. It lays out three ways platforms are selling “SpaceX IPO access” ahead of listing.
First, there’s a plain allocation at $135. US brokers including Robinhood, Fidelity, Charles Schwab, SoFi and Morgan Stanley’s E*Trade handle US customer allocations, while Kraken and Bybit are said to be packaging the same allocation for users elsewhere.
Second, there’s synthetic exposure. Binance launched an SPCXUSDT perpetual in May, around the same time CMC Markets opened grey-market SpaceX spread bets and CFDs. OKX, Gate, BingX and Hyperliquid are described as running comparable products.
Third, some platforms route buyers through private secondary markets or special purpose vehicles for accredited investors. The report cites Forge and Hiive, with Hiive listing SpaceX shares near $832 a unit in April.
Those are not interchangeable products. The gap matters most after the money leaves your account.
Three mechanisms, opposite risk profiles
The desk in the Finance Magnates piece keeps returning to two mechanisms. Allocations and synthetic products work in different directions.
An allocation involves a subscription window. An underwriting syndicate decides the allotment. Buyers do not own stock until the stock prices and lists. The report quotes Arkadiusz Jóżwiak, editor-in-chief at Comparic.pl, on broker pre-market share allocations, and quotes Dan Coatsworth of AJ Bell saying allocation terms finalize when the offer period closes. He adds that it cannot be ruled out that retail investors could receive nothing.
Synthetic routes skip stock entirely. The venue quotes a private-company price and then lets clients trade a derivative against it. Finance Magnates points out that this is how grey-market CFDs and pre-IPO perpetual futures can run for months before any allocation exists. In that setup, buyers are betting on price movement tied to expectations, not on owning equity.
Kraken and Bybit push tokenized allocation
The most direct crypto pitch in the story comes from Kraken and Bybit, both routing their offerings through xStocks, described as a tokenization framework run by Kraken’s parent, Payward.
Kraken moved first on June 5, and Bybit followed on June 7 by opening subscriptions to a tokenized SpaceX offering at the IPO price. Finance Magnates says both promise allocations settled when SpaceX starts trading June 12.
The timing lines up tightly with the listing date. The report also cites a public post from Elon Musk on June 4 referencing IPO information, and it says Bybit is the second crypto exchange in three days to offer ordinary investors a way to buy into the IPO at its offer price.
Kraken’s token is described as available in more than 110 countries including the European Economic Area. Payward Co-CEO Arjun Sethi is quoted as framing tokenization around access exclusion, saying best IPOs have historically opened “behind a velvet rope.”
Bybit’s subscription window runs June 7 to June 11, with pro-rata allocation, automatic refunds on unused funds, and spot trading starting June 12. Finance Magnates quotes Bybit’s head of spot, Emily Bao, saying retail had been shut out for decades.
“Bet” products and token wrappers carry different consequences
Finance Magnates draws a sharp line between allocation rules and synthetic liquidity.
With an oversubscribed book, applying is not the same as receiving. The report notes that some US brokers may scale fills back through lottery, while exchanges handle scaling pro-rata. It also flags a marketing tension. SpaceX and the US brokers rely on anti-flipping rules aimed at encouraging holding, while tokenized versions are promoted as 24/7 liquidity, including during traditional market closures.
The report also points to a valuation reality check. Morningstar analyst Nicolas Owens, cited in Finance Magnates, wrote that the company is overvalued and that investors may get chances to buy at more attractive levels after the IPO.
Tokenization here is not new. The desk recalls that Robinhood pushed tokenized SpaceX and OpenAI products to European users in June 2025, which drew scrutiny from the Bank of Lithuania. The story also notes an OpenAI statement that those tokens did not represent OpenAI equity.
There’s still an unresolved question in the Finance Magnates piece: whether tokenized exposure beats CFDs in any practical sense. Kraken and Bybit are said to wrap the allocation itself in a token, rather than just tracking it, but the regulatory and settlement mechanics will be tested in the post-listing period.
Where the SEC and CFTC could get involved
The report’s risk framing is blunt. It argues that synthetic and grey-market offerings carry the most regulatory exposure if the SEC or CFTC starts asking questions after listing.
It also notes geographic divergence. Finance Magnates says Kraken’s token is not available to US persons and is characterized as price exposure only, without voting or dividend rights. It also mentions MEXC routing orders for real US shares through a licensed broker, implying not all crypto desks are offering the same rights model.
Finally, the story points to the math of supply as the common problem underneath all channels. When the oversubscription meets lotteries and pro-rata scaling, the investor’s experience diverges sharply across products.
Key dates and product types (from the report)
| Item | What the report says | Why it matters |
|---|---|---|
| SpaceX trading start | Nasdaq June 12 | Settlement and rights become knowable only after the first listed prints |
| Pricing | 555.6 million shares at $135 | Sets the offer-price reference point for any allocation product |
| Fundraise estimate | About $75 billion | Confirms scale and explains why the book is oversubscribed |
| Retail allocation | Up to 30% set aside for retail via US brokers | Bigger retail slice triggered crypto replication attempts |
| Bybit subscription window | June 7 to June 11 | Determines whether a buyer is using allocation timing versus ongoing derivative pricing |
| Synthetic products cited | Binance SPCXUSDT perpetual, grey-market CFDs and spread bets | Buyers are trading derivatives tied to expectations, not equity until shares list |
So what breaks first: access or expectations
The Finance Magnates report leaves one operational truth. Buyers won’t learn whether they truly bought a share, a tokenized allocation, or a synthetic bet until after SPCX begins trading.
That’s the line to watch, not the marketing label. And given the report’s mention of SEC sensitivity and Musk’s long history of promoting assets on X, enforcement questions could show up only when regulators decide the trading structure needs clearer edges.